Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Revenues:        
License and collaborative fees $ 275 $ 945 $ 2,766 $ 1,207
Contract and other 168 1,594 1,639 3,983
Total revenues 443 2,539 4,405 5,190
Operating expenses:        
Research and development 13,703 19,692 27,313 39,696
Selling, general and administrative 4,779 5,060 9,084 10,280
Restructuring (21)   15  
Total operating expenses 18,461 24,752 36,412 49,976
Loss from operations (18,018) (22,213) (32,007) (44,786)
Other income (expense):        
Interest expense (1,007) (1,007) (2,009) (2,123)
Other income (expense), net 602 (363) 296 1,648
Revaluation of contingent warrant liabilities 3,263 (176) 10,195 (216)
Net loss $ (15,160) $ (23,759) $ (23,525) $ (45,477)
Basic and diluted net loss per share of common stock $ (0.13) $ (0.20) $ (0.20) $ (0.39)
Shares used in computing basic and diluted net loss per share of common stock 120,448 117,540 120,008 116,870
Other comprehensive loss:        
Net loss $ (15,160) $ (23,759) $ (23,525) $ (45,477)
Net unrealized loss on marketable securities (12)   (54)  
Comprehensive loss $ (15,172) $ (23,759) $ (23,579) $ (45,477)